Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Rapport Therapeutics Inc (RAPP)

36,10

-1,39

(-3,71%)

Fermé 07 Juin 10:00PM

35,38

-0,72

(-1,99%)

Après les heures de négociation: 1:46AM

Rapport Therapeutics Inc ([symbol]) Options

RAPP Flux des options

Achats

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
17,50	16,00	21,00	0,00	18,50	0,00	0,00 %	0	0	-
20,00	14,50	18,50	0,00	16,50	0,00	0,00 %	0	0	-
22,50	11,50	16,00	0,00	13,75	0,00	0,00 %	0	0	-
25,00	9,50	13,50	0,00	11,50	0,00	0,00 %	0	0	-
27,50	6,50	11,00	0,00	8,75	0,00	0,00 %	0	0	-
30,00	4,40	9,00	0,00	6,70	0,00	0,00 %	0	0	-
32,50	2,80	6,50	0,00	4,65	0,00	0,00 %	0	0	-
35,00	1,45	4,90	2,39	3,175	0,69	40,59 %	15	52	05/6/2026
37,50	0,10	4,90	0,00	2,50	0,00	0,00 %	0	0	-
40,00	0,10	4,90	2,50	2,50	0,00	0,00 %	0	22	-
42,50	0,05	4,90	1,35	2,475	0,00	0,00 %	0	10	-
45,00	0,10	4,90	0,00	2,50	0,00	0,00 %	0	0	-
47,50	0,00	4,90	0,90	0,90	0,00	0,00 %	0	1	-
50,00	0,00	4,90	0,50	0,50	0,00	0,00 %	0	2	-
55,00	0,00	4,90	0,00	0,00	0,00	0,00 %	0	0	-

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Ventes

Strike	Achat	Vente	Dernier Prix	Point Médian	Var	Var %	Volume	INT OUVERT	Dernière Trans
17,50	0,00	5,00	0,00	0,00	0,00	0,00 %	0	0	-
20,00	0,00	4,90	0,00	0,00	0,00	0,00 %	0	0	-
22,50	0,00	4,90	0,00	0,00	0,00	0,00 %	0	0	-
25,00	0,00	4,90	0,00	0,00	0,00	0,00 %	0	0	-
27,50	0,00	4,90	0,00	0,00	0,00	0,00 %	0	0	-
30,00	0,00	1,50	0,00	0,00	0,00	0,00 %	0	0	-
32,50	0,10	4,90	1,00	2,50	0,00	0,00 %	0	251	-
35,00	0,10	4,10	2,15	2,10	0,00	0,00 %	0	100	-
37,50	0,50	4,90	1,90	2,70	0,00	0,00 %	0	1	-
40,00	2,00	6,30	2,90	4,15	0,00	0,00 %	0	20	-
42,50	4,00	8,80	0,00	6,40	0,00	0,00 %	0	0	-
45,00	6,50	11,40	0,00	8,95	0,00	0,00 %	0	0	-
47,50	9,00	13,50	0,00	11,25	0,00	0,00 %	0	0	-
50,00	11,50	16,20	0,00	13,85	0,00	0,00 %	0	0	-
55,00	16,50	21,20	0,00	18,85	0,00	0,00 %	0	0	-

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
SCAGScage Future	US$ 0,8489 (196,61%)	92,75M
SPHLSpringview Holdings Ltd	US$ 5,38 (125,20%)	40,61M
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M
STISolidion Technology Inc	US$ 35,50 (56,32%)	38,55M
NUWENewellis Inc	US$ 0,1625 (-62,30%)	50M
NYXHNyxoah SA	US$ 1,41 (-51,04%)	2,47M
CYPHCypherpunk Technologies Inc	US$ 0,5176 (-47,26%)	30,53M
TDICDreamland Ltd	US$ 0,2277 (-37,68%)	12,09M
FOFOHang Feng Technology Innovation Co Ltd	US$ 3,91 (-36,73%)	381,9k
NOTVInotiv Inc	US$ 0,1638 (89,15%)	1,07B
SNBRSleep Number Corporation	US$ 0,477 (36,25%)	305,13M
SMTKSmartKem Inc	US$ 0,419101 (30,97%)	232,19M
NVDANVIDIA Corporation	US$ 205,10 (-6,20%)	220,65M
RMSGReal Messenger Corporation	US$ 1,809 (64,45%)	199,97M

jbog

jbog il y a 6 minutes

Eli Lilly reports broad benefits for experimental obesity drug retatrutide
Jun 06, 2026, 5:37 PM ETEli Lilly and Company (LLY) StockBy: Rob Williams, SA News Editor

Share

Save

Play
(5min)
Comments
(5)
Eli Lilly (LLY) on

Adam

Adam il y a 7 minutes

How do you guys handle a large influx of shares into an AIM program? I was assigned on two sold puts so I had an influx of shares of 200 shares on top of the prior 440 shares. At first I entered it as a regular buy and my spreadsheet immediately went into a sell mode. So instead I increased Portfol

Newtogame

Newtogame il y a 9 minutes

Tazzie 5-20-24-19 Moose 45-11-24-19 Chance 11-20-19-24 New5-20-19-24
GLTA

bb8675309

bb8675309 il y a 11 minutes

The Journal of Prevention of Alzheimer's Disease
Volume 12, Issue 1, January 2025, 100016

Blarcamesine was endorsed by 58 of the worlds best CNS Doctors/ Scientist thru peer review study. [/b This is currently the safest CNS drug invented to date with over 9 plus years of prove

PickStocks

PickStocks il y a 12 minutes

Sure….not yet…⏰⏱️⌛️⏳

DrHigh

DrHigh il y a 12 minutes

Careful flip, you will be accused of shilling for shorts if you dare question LP’s excellent oversight of our investment which has lost 99%+ during her reign

gedi8

gedi8 il y a 13 minutes

Great post. You have brought the issue of assay results into perspective with reality and as some of us have said all along that comprehensive and complete analysis takes time. Thanks

Kool Aid Man

Kool Aid Man il y a 16 minutes

So Friday's announcement=an official attempt to deceive/stall/lull investors?

How can it be otherwise in light of the DD you have unearthed?

What are the penalties/ sanctions for such ham-handed attempts to whitewash the facts?

ORCA

ORCA il y a 18 minutes

BARCHART HAS ETH AT 100% SELL IN ALL FRONTS.
Ethereum - USD (^ETHUSD)
1,567.200 -37.280 (-2.32%) 19:21 CT [CRYPTO]

Mr. C

Mr. C il y a 21 minutes

It’s not always formal and sometimes simply correspondence or maybe it hasn’t been released yet.

Either way, it didn’t prevent FID, so I doubt it stands in the way of merger

ORCA

ORCA il y a 22 minutes

IF THE DIVY DOES NOT COME WE SHOULD SEE .0007???LETS DO IT.I WOULD LOVE TO SEE .0007 SOMETIME NEXT WEEK BRO.

mascale

mascale il y a 25 minutes

skitahoe

skitahoe il y a 28 minutes

GGB, I hope you're right, I believe the SEC tends to look at the OTC and Pinks much like they're the wild west and rarely pursue what manipulation occurs there.

I believe that LP knows a lot of people and most certainly Cofer Black knows where the bodies are buried, if they wish to p

uber darthium

uber darthium il y a 29 minutes

May I predict that the families of these AMFN BAGHOLDERS will more likely than not be stepping in during the coming weeks to do whatever to protect their misled “sheep” loved ones, themselves and their families’ financial future and set up my internal controls preventing these “old” sheep from “inve

jerkviewer

jerkviewer il y a 31 minutes

if we dont sell....can you imagine us making about 500 million a month in a few years.....boom

EddytheEagle

EddytheEagle il y a 31 minutes

Direct has been sitting on the back shelf for 10 years now. That doesn't exactly give it blockbuster status. If it had good potential don't you think a BP would have bought it and provided NWBO with some desperately needed cash? Good luck with that. And as for -L, its been 2 1/2 yrs since they filed

waterchaser

waterchaser il y a 34 minutes

jerkviewer

jerkviewer il y a 36 minutes

apparently this eloquis filing could be raising the price tag of elite several times..... if they can get the big boys to even believe just a little that it could happen and we could get around the patents...then we could get a bidding war or at least a damn good price

Rhodan

Rhodan il y a 38 minutes

Where is that Return to Service guidance reported? Delfin marches forward in an arrow straight line.

Stumblebum

Stumblebum il y a 40 minutes

Still holding BMEA 💵💰

Duke Knockem

Duke Knockem il y a 41 minutes

he publicly mentioned on Twitter and here that he loaded ENCC... I had pinned his comment screenshot on here on the board when I was a moderator but somehow someone deleted all of my pinned pictures related to this security.

Mr. C

Mr. C il y a 41 minutes

What? They probably already did and I highly doubt that has anything to do with merger versus preventing the FID that we just got.

Keep in mind, it takes well over a year to clear those cases, so it isn’t going anywhere, but that does not mean they didn’t receive a return to service w

TooFrank

TooFrank il y a 42 minutes

NIO has no exposure, Wall Street has no discernment.

The European Union and China are edging closer to a full-scale trade war as the bloc moves to protect its struggling manufacturing sector from a massive surge of subsidized Chinese imports.
Over a recent five-year period, Ch

Optimus Research

Optimus Research il y a 42 minutes

Linda Powers will be a trillionaire before Elon Musk. How do you like them apples??

Cambreau

Cambreau il y a 42 minutes

Wouldn't be surprised if this dips sub .50 like it did end of 2022. Very frustrating , to say the least.

Rapport Therapeutics

Invesco ETF Trust Invesc...

ARS Pharmaceuticals

Morgan Creek Exos Active...

First Trust Dorsey Wrigh...

iShares MSCI KLD 400 Soc...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.